Meeting
2017 ASCO Annual Meeting
Phase I trial of dimethyl fumarate, temozolomide, and radiation therapy in glioblastoma multiforme.
Authors
Danielle A. Shafer
Virginia Commonwealth University, Richmond, VA
Danielle A. Shafer , Zhi-jian Chen , Timothy Harris , Mary Beth Tombes , Ellen Shrader , Kathryn Strickler , Alison A. Ryan , Paul Dent , Mark Gordon Malkin
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Central Nervous System Tumors
Clinical Trial Registration Number
NCT02337426
Citation
J Clin Oncol 35, 2017 (suppl; abstr 2060)
DOI
10.1200/JCO.2017.35.15_suppl.2060
Abstract #
2060
Poster Bd #
302
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Phase I study of afatinib and radiotherapy (RT) with or without temozolomide (TMZ) in newly diagnosed glioblastoma (GB).
First Author: Frank Saran
Poster
2020 Gastrointestinal Cancers Symposium
Phase I dose-escalation trial of trifluridine/tipiracil (TAS-102) and temozolomide in the treatment of advanced neuroendocrine tumors.
First Author: Nataliya Volodymyrivna Uboha
Poster
2019 ASCO Annual Meeting
Phase I study of procaspase activating compound -1 (PAC-1) in combination with temozolomide (TMZ) for the treatment of recurrent malignant glioma.
First Author: Martin Kelly Nicholas
Poster
2019 ASCO Annual Meeting
A TITE-CRM phase I/II study of disulfiram and copper with concurrent radiation therapy and temozolomide for newly diagnosed glioblastoma.
First Author: Jiayi Huang